Mike Matson
Stock Analyst at Needham
(3.42)
# 973
Out of 4,749 analysts
482
Total ratings
48.32%
Success rate
3.83%
Average return
Main Sectors:
Stocks Rated by Mike Matson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RMD ResMed | Reiterates: Hold | n/a | $236.18 | - | 14 | Jan 31, 2025 | |
| SRDX Surmodics | Reiterates: Hold | n/a | $34.04 | - | 20 | Jan 30, 2025 | |
| INGN Inogen | Reiterates: Hold | n/a | $11.69 | - | 15 | Jan 30, 2025 | |
| FNA Paragon 28 | Downgrades: Hold | $13 | $13.02 | -0.15% | 16 | Jan 29, 2025 | |
| VCYT Veracyte | Maintains: Buy | $44 → $51 | $45.48 | +12.14% | 15 | Jan 29, 2025 | |
| SYK Stryker | Reiterates: Buy | $442 | $391.29 | +12.96% | 7 | Jan 29, 2025 | |
| MMSI Merit Medical Systems | Maintains: Buy | $109 → $122 | $108.88 | +12.05% | 23 | Jan 29, 2025 | |
| ZBH Zimmer Biomet Holdings | Reiterates: Hold | n/a | $109.48 | - | 25 | Jan 29, 2025 | |
| AORT Artivion | Reiterates: Buy | $34 | $30.96 | +9.82% | 15 | Jan 28, 2025 | |
| LIVN LivaNova | Reiterates: Buy | $75 | $49.95 | +50.15% | 23 | Jan 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $51 | $39.87 | +27.92% | 30 | Jan 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $174.23 | - | 23 | Jan 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $19 | $14.30 | +32.87% | 23 | Jan 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $42 | $24.00 | +75.00% | 20 | Jan 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $90 | $72.14 | +24.76% | 17 | Jan 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7.25 | $5.22 | +38.89% | 18 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $180.24 | - | 8 | Dec 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $67.55 | - | 6 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $112 | $69.05 | +62.20% | 10 | Dec 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $102.36 | - | 25 | Nov 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $90.82 | - | 15 | Nov 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $2.5 | $0.96 | +160.99% | 16 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $4.25 | $2.07 | +105.31% | 15 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $164.36 | - | 4 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $220.65 | - | 10 | Nov 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $65 | $46.98 | +38.36% | 11 | Nov 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $266.97 | - | 9 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $97 | $71.78 | +35.14% | 22 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $17.21 | - | 15 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $79.67 | - | 9 | Oct 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $34 → $42 | $16.76 | +150.60% | 2 | May 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $65 → $75 | $92.72 | -19.11% | 1 | Feb 18, 2021 |
ResMed
Jan 31, 2025
Reiterates: Hold
Price Target: n/a
Current: $236.18
Upside: -
Surmodics
Jan 30, 2025
Reiterates: Hold
Price Target: n/a
Current: $34.04
Upside: -
Inogen
Jan 30, 2025
Reiterates: Hold
Price Target: n/a
Current: $11.69
Upside: -
Paragon 28
Jan 29, 2025
Downgrades: Hold
Price Target: $13
Current: $13.02
Upside: -0.15%
Veracyte
Jan 29, 2025
Maintains: Buy
Price Target: $44 → $51
Current: $45.48
Upside: +12.14%
Stryker
Jan 29, 2025
Reiterates: Buy
Price Target: $442
Current: $391.29
Upside: +12.96%
Merit Medical Systems
Jan 29, 2025
Maintains: Buy
Price Target: $109 → $122
Current: $108.88
Upside: +12.05%
Zimmer Biomet Holdings
Jan 29, 2025
Reiterates: Hold
Price Target: n/a
Current: $109.48
Upside: -
Artivion
Jan 28, 2025
Reiterates: Buy
Price Target: $34
Current: $30.96
Upside: +9.82%
LivaNova
Jan 28, 2025
Reiterates: Buy
Price Target: $75
Current: $49.95
Upside: +50.15%
Jan 22, 2025
Maintains: Buy
Price Target: $40 → $51
Current: $39.87
Upside: +27.92%
Jan 22, 2025
Reiterates: Hold
Price Target: n/a
Current: $174.23
Upside: -
Jan 15, 2025
Reiterates: Buy
Price Target: $19
Current: $14.30
Upside: +32.87%
Jan 14, 2025
Reiterates: Buy
Price Target: $42
Current: $24.00
Upside: +75.00%
Jan 13, 2025
Reiterates: Buy
Price Target: $90
Current: $72.14
Upside: +24.76%
Jan 8, 2025
Maintains: Buy
Price Target: $7.25
Current: $5.22
Upside: +38.89%
Dec 16, 2024
Reiterates: Hold
Price Target: n/a
Current: $180.24
Upside: -
Dec 11, 2024
Reiterates: Hold
Price Target: n/a
Current: $67.55
Upside: -
Dec 3, 2024
Reiterates: Buy
Price Target: $112
Current: $69.05
Upside: +62.20%
Nov 27, 2024
Reiterates: Hold
Price Target: n/a
Current: $102.36
Upside: -
Nov 20, 2024
Reiterates: Hold
Price Target: n/a
Current: $90.82
Upside: -
Nov 14, 2024
Reiterates: Buy
Price Target: $2.5
Current: $0.96
Upside: +160.99%
Nov 13, 2024
Reiterates: Buy
Price Target: $4.25
Current: $2.07
Upside: +105.31%
Nov 13, 2024
Reiterates: Hold
Price Target: n/a
Current: $164.36
Upside: -
Nov 8, 2024
Reiterates: Hold
Price Target: n/a
Current: $220.65
Upside: -
Nov 7, 2024
Reiterates: Buy
Price Target: $65
Current: $46.98
Upside: +38.36%
Oct 31, 2024
Reiterates: Hold
Price Target: n/a
Current: $266.97
Upside: -
Oct 31, 2024
Reiterates: Buy
Price Target: $97
Current: $71.78
Upside: +35.14%
Oct 31, 2024
Reiterates: Hold
Price Target: n/a
Current: $17.21
Upside: -
Oct 30, 2024
Reiterates: Hold
Price Target: n/a
Current: $79.67
Upside: -
May 4, 2021
Maintains: Buy
Price Target: $34 → $42
Current: $16.76
Upside: +150.60%
Feb 18, 2021
Maintains: Buy
Price Target: $65 → $75
Current: $92.72
Upside: -19.11%